Alert-Based ePRO Monitoring Reduces Fatigue and Improves Physical Functioning in Metastatic Breast Cancer Patients

Results from the multicenter PRO B trial, published in JAMA Oncology, demonstrate that weekly electronic patient-reported outcome (ePRO) monitoring with alert-based clinical response significantly reduced fatigue and improved physical functioning in women with metastatic breast cancer compared to usual care. This approach offers a new method for symptom management and potentially better patient outcomes.